Brief: Pherecydes Pharma Get Non-Dilutive Financing From Bpifrance
29/04/2021 17:18
April 29 (Reuters) - PHERECYDES PHARMA SA ALPHE.PA :
* PHERECYDES PHARMA OBTAINS €2 MILLION IN NON-DILUTIVE
FINANCING
FROM BPIFRANCE
* FINANCING HAS BEEN GRANTED WITHIN FRAMEWORK OF
"STATE-GUARANTEED
LOAN - INNOVATION SUPPORT" SCHEME
* WILL HAVE POSSIBILITY, AFTER FIRST YEAR, OF AMORTIZING
LOAN OVER
A DURATION OF UP TO 5 YEARS
Source text for Eikon: ID:nBw3qqpTJa
Further company coverage: ALPHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Pherecydes Pharma SA
See all newsBrief: Erytech And Pherecydes Announce Merger And Name Change To Phaxiam Therapeutics
Brief: Pherecydes Pharma SA - Pherecydes Pharma And Erytech Pharma Shareholders Approve Merger Between Two Companies To Create Phaxiam Therapeutics
Brief: Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma
Brief: Erytech: urges shareholders to vote for merger with Pherecydes and dismisses Akkadian's moves
Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes